The absence of residual disease after cytoreductive surgery (CRS) is the most important prognostic factor in the management of patients with advanced ovarian cancer (AOC). As a result, the therapeutic approach to these patients is based primarily on disease...
Abstract: Background: Ovarian cancer has a low incidence, but high mortality due to a habitual diagnosis in advanced cancer stages. Currently, used biomarkers have good sensitivity, but low specificity. Aim: To determine the usefulness of the biomarkers and...
La Càtedra Medtronic de formación e investigación quirúrgica ha organizado los pasados días 6 y 13 de mayo dos cursos de Simulación en Emergencias Obstétricas en las instalaciones de la Facultad de Ciencias de la Salud de la Universitat Jaume I de Castelló. En el...
Introduction: Medical models assist clinicians in making diagnostic and prognostic decisions in complex situations. In advanced ovarian cancer, medical models could help prevent unnecessary exploratory surgery. We designed two models to predict suboptimal or complete...
La conselleria de Sanidad Universal y Salud Pública ha nombrado a la Unidad Multidisciplinar de Cirugía Oncológica Abdominal-pélvica (Umcoap) ubicada en el Hospital General de Castelló como la unidad de referencia de los hospitales de Vinaròs, La Plana y el Hospital...
